Skip to main content
Akoya Biosciences, Inc. (AKYA)
NASDAQ: AKYA · IEX Real-Time Price · USD
2.460
+0.020 (0.82%)
Jul 26, 2024, 4:30 PM EDT - Market closed

Akoya Biosciences Revenue

Akoya Biosciences had revenue of $18.35M in the quarter ending March 31, 2024, a decrease of -14.29%. This brings the company's revenue in the last twelve months to $93.57M, up 17.89% year-over-year. In the year 2023, Akoya Biosciences had annual revenue of $96.63M with 29.09% growth.

Revenue (ttm)
$93.57M
Revenue Growth
+17.89%
P/S Ratio
1.30
Revenue / Employee
$283,555
Employees
330
Market Cap
121.49M

Revenue Chart

History

Fiscal Year End Revenue Change Growth
Dec 31, 202396.63M21.77M29.09%
Dec 31, 202274.86M19.94M36.31%
Dec 31, 202154.92M12.47M29.39%
Dec 31, 202042.44M207.00K0.49%
Dec 31, 201942.24M--
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name Revenue
Karyopharm Therapeutics 140.46M
FONAR 102.72M
KORU Medical Systems 29.32M
Sangamo Therapeutics 18.76M
Werewolf Therapeutics 16.22M
Revenue Rankings

AKYA News

More News